ONKOLOGIK KASALLIKLARNING ERTA DIAGNOSTIKASI VA BIOMARKERLAR ROLI
Keywords:
Kalit so‘zlar: Onkologik kasallik, biomarker, likvid biopsiya, genetik testlar, diagnostika.Abstract
Annotatsiya: Onkologik kasalliklar global sog‘liqni saqlash tizimi oldida turgan dolzarb muammolardan biri hisoblanadi. Saratonni erta bosqichda aniqlash bemorning yashash muddatini uzaytirish va hayot sifatini saqlashda muhim rol o‘ynaydi. Ushbu maqolada onkologik biomarkerlar, ularning turlari, qo‘llanilish yo‘nalishlari va zamonaviy texnologiyalar asosida erta diagnostikaning ahamiyati yoritilgan.
References
1. WHO. Global cancer statistics. World Health Organization, 2023.
2. Henry NL, Hayes DF. Cancer biomarkers. Molecular Oncology. 2012;6(2):140-146.
3. Catalona WJ. Prostate-specific antigen (PSA) testing. N Engl J Med. 1994.
4. Mavaddat N et al. Cancer risks associated with BRCA1 and BRCA2 mutations. JAMA, 2021.
5. Lièvre A et al. KRAS mutation status and response to cetuximab. J Clin Oncol. 2006.
6. Wan JCM et al. Liquid biopsies come of age: towards implementation. Nat Rev Cancer. 2017.
7. Slamon DJ et al. Use of chemotherapy plus a monoclonal antibody against HER2. N Engl J Med. 2001.
8. Jameson JL, Longo DL. Precision medicine—personalized, problematic, and promising. N Engl J Med. 2015.
